Trajectories of body mass index before the diagnosis of cardiovascular disease: a latent class trajectory analysis

European Journal of Epidemiology

Volumn 31, Issue 6, 2016, Pages 583-592

  Dhana, Klodian ^a   van Rosmalen, Joost ^a   Vistisen, Dorte ^b   Ikram, M Arfan ^a   Hofman, Albert ^a,c   Franco, Oscar H ^a   Kavousi, Maryam ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b STENO DIABETES CENTER   (Denmark)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Blood pressure; Body mass index; Cardiovascular disease; Glucose; Lipids; Obesity physiopathology

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL EXAMINATION; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; POPULATION RESEARCH; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WEIGHT GAIN; WEIGHT REDUCTION; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; HEALTH SURVEY; NETHERLANDS; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

AGED; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; OBESITY; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK FACTORS; WAIST CIRCUMFERENCE; WEIGHT GAIN;

EID: 84960110098     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-016-0131-0     Document Type: Article

References (29)

1. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67(5):968–77.
2. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341(15):1097–105.
3. Nordestgaard BG, Palmer TM, Benn M, et al. The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach. PLoS Med. 2012;9(5):e1001212.
4. Reis JP, Loria CM, Lewis CE, et al. Association between duration of overall and abdominal obesity beginning in young adulthood and coronary artery calcification in middle age. JAMA. 2013;310(3):280–8.
5. Abdullah A, Amin FA, Stoelwinder J, et al. Estimating the risk of cardiovascular disease using an obese-years metric. BMJ Open. 2014;4(9):e005629.
6. Brancati FL, Wang NY, Mead LA, Liang KY, Klag MJ. Body weight patterns from 20 to 49 years of age and subsequent risk for diabetes mellitus: the Johns Hopkins Precursors Study. Arch Intern Med. 1999;159(9):957–63.
7. Abdullah A, Wolfe R, Stoelwinder JU, et al. The number of years lived with obesity and the risk of all-cause and cause-specific mortality. Int J Epidemiol. 2011;40(4):985–96.
8. Gao W, Group DS. Does the constellation of risk factors with and without abdominal adiposity associate with different cardiovascular mortality risk? Int J Obes. 2008;32(5):757–62.
9. Wilson PW, D’Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162(16):1867–72.
10. Proust-Lima C, Letenneur L, Jacqmin-Gadda H. A nonlinear latent class model for joint analysis of multivariate longitudinal data and a binary outcome. Stat Med. 2007;26(10):2229–45.
11. Vistisen D, Witte DR, Tabak AG, et al. Patterns of obesity development before the diagnosis of type 2 diabetes: the Whitehall II cohort study. PLoS Med. 2014;11(2):e1001602.
12. Hofman A, Brusselle GG, Darwish Murad S, et al. The Rotterdam study: 2016 objectives and design update. Eur J Epidemiol. 2015;30(8):661–708.
13. Koller MT, Leening MJ, Wolbers M, et al. Development and validation of a coronary risk prediction model for older U.S. and European persons in the Cardiovascular Health Study and the Rotterdam Study. Ann Intern Med. 2012;157(6):389–97. doi:10.7326/0003-4819-157-6-201209180-00002.
14. Kavousi M, Elias-Smale S, Rutten JH, et al. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann Intern Med. 2012;156(6):438–44.
15. Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2935–59. doi:10.1016/j.jacc.2013.11.005.
16. Bos MJ, Koudstaal PJ, Hofman A, Ikram MA. Modifiable etiological factors and the burden of stroke from the Rotterdam Study: a population-based cohort study. PLoS Med. 2014;. doi:10.1371/journal.pmed.1001634.
17. Zajacova A, Ailshire J. Body mass trajectories and mortality among older adults: a joint growth mixture-discrete-time survival analysis. Gerontologist. 2014;54(2):221–31. doi:10.1093/geront/gns164.
18. Grundy SM, Becker D, Clark LT, et al. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–421.
19. Rimm EB, Stampfer MJ, Giovannucci E, et al. Body-size and fat distribution as predictors of coronary heart-disease among middle-aged and older US men. Am J Epidemiol. 1995;141(12):1117–27.
20. Stevens J, Cai JW, Pamuk ER, Williamson DF, Thun MJ, Wood JL. The effect of age on the association between body-mass index and mortality. N Engl J Med. 1998;338(1):1–7. doi:10.1056/Nejm199801013380101.
21. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005;293(15):1861–7.
22. Dhana K, Ikram MA, Hofman A, Franco OH, Kavousi M. Anthropometric measures in cardiovascular disease prediction: comparison of laboratory-based versus non-laboratory-based model. Heart. 2014;. doi:10.1136/heartjnl-2014-306704.
23. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309(1):71–82.
24. Streiner DL. Breaking up is hard to do: the heartbreak of dichotomizing continuous data. Can J Psychiatry. 2002;47(3):262–6.
25. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881–7. doi:10.1038/nature05488.
26. Quagliaro L, Piconi L, Assaloni R, Maier A, Motz E, Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells. The role of protein kinase C and NAD (P) H oxidase activation. Diabetes. 2003;52:2795–804.
27. Chang CM, Hsieh CJ, Huang JC, Huang IC. Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus. Acta Diabetol. 2012;49:S171–7. doi:10.1007/s00592-012-0398-x.
28. Ingram DD, Mussolino ME. Weight loss from maximum body weight and mortality: the Third National Health and Nutrition Examination Survey Linked Mortality File. Int J Obes. 2010;34(6):1044–50.
29. Finkelstein EA, Ostbye T, Malhotra R. Body mass trajectories through midlife among adults with class I obesity. Surg Obes Relat Dis. 2013;9(4):547–53.